2018
DOI: 10.1016/j.aca.2018.03.016
|View full text |Cite
|
Sign up to set email alerts
|

A sensitive detection assay based on signal amplification technology for Alzheimer's disease's early biomarker in exosome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(13 citation statements)
references
References 41 publications
0
11
0
Order By: Relevance
“…However, these methods need high-cost equipment, complicated sample processing and long runtime, and are therefore not suitable for high-throughput routine clinical trials and scientific research applications [22][23][24]. Because of their low detection limit and high selectivity, fluorescent probes have been used for the quantitative detection of biothiols [25][26][27][28]. Cho's group [29] reported a two-photon fluorescent probe for the detection of thiols based on a thiol/disulfide exchange.…”
Section: Introductionmentioning
confidence: 99%
“…However, these methods need high-cost equipment, complicated sample processing and long runtime, and are therefore not suitable for high-throughput routine clinical trials and scientific research applications [22][23][24]. Because of their low detection limit and high selectivity, fluorescent probes have been used for the quantitative detection of biothiols [25][26][27][28]. Cho's group [29] reported a two-photon fluorescent probe for the detection of thiols based on a thiol/disulfide exchange.…”
Section: Introductionmentioning
confidence: 99%
“…The latter will be emphasized in this Commentary. A notable example of the former role is detection in blood of exosomes that contain Alzheimer disease-specific oligomeric proteins and thereby providing the potential to provide ultrasensitive early detection of Alzheimer disease [ 25 ]. Concerning the latter role, increasing evidence indicates that exosomes from MSCs mediate the beneficial effects of stem cell therapy in various pathological neurological states, including perinatal brain injury (see later).…”
Section: Exosomesmentioning
confidence: 99%
“…Considering the above, the use of exosome-associated Aβ oligomers for early detection of Alzheimer's disease has been trending and along with other targets is the subject of patents. A contemporarily declared technology used aptasensors for detection of picomolar concentrations of Aβ42 in blood of suspected AD subjects [79]. It is rationalized that the utility of the exosomes within the developed strategy stems from their ability to cross the blood brain barrier.…”
Section: Exosomes In Neurological Disordersmentioning
confidence: 99%